Literature DB >> 23657536

[Patients at the end of life in the intensive care unit: cultural aspects of accompaniment].

I-U Grom1, D A Vagts, U Kampa, G Pfeiffer, L Schreiber-Winzig, C H R Wiese.   

Abstract

The accompaniment of people in the face of death offers insights into dimensions which are mostly not seen in ordinary life. These insights also exist in intensive care in German hospitals and are highly relevant in medical decision making. End-of-life decisions in particular often determine medical, cultural and spiritual aspects concerning medical treatment and therapeutic targets and if necessary new therapy targets. The following article especially illuminates cultural aspects and their characteristics in patients at the end of life in the intensive care unit.

Entities:  

Mesh:

Year:  2013        PMID: 23657536     DOI: 10.1007/s00101-013-2174-x

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  13 in total

1.  [History of the development of intensive care medicine. Contemporary considerations. 3. Structural development of operative intensive care medicine. Part I].

Authors:  P Lawin; H W Opderbecke; H P Schuster
Journal:  Anaesthesist       Date:  1999-02       Impact factor: 1.041

2.  [The history of the development of intensive care medicine in Germany. Contemporary reflections. 3. Structural development of operative intensive care medicine. II].

Authors:  P Lawin; H W Opderbecke; H P Schuster
Journal:  Anaesthesist       Date:  1999-03       Impact factor: 1.041

3.  [Physician-patient-family relationship--a core element of a successful intensive care therapy?].

Authors:  T Wurmb; N Roewer
Journal:  Dtsch Med Wochenschr       Date:  2011-12-16       Impact factor: 0.628

4.  Attitudes of European physicians, nurses, patients, and families regarding end-of-life decisions: the ETHICATT study.

Authors:  Charles L Sprung; Sara Carmel; Peter Sjokvist; Mario Baras; Simon L Cohen; Paulo Maia; Albertus Beishuizen; Daniel Nalos; Ivan Novak; Mia Svantesson; Julie Benbenishty; Beverly Henderson
Journal:  Intensive Care Med       Date:  2006-10-26       Impact factor: 17.440

Review 5.  Forgoing life sustaining treatments: differences and similarities between North America and Europe.

Authors:  N M Moselli; F Debernardi; F Piovano
Journal:  Acta Anaesthesiol Scand       Date:  2006-11       Impact factor: 2.105

6.  Population aging and hospitalization for chronic disease in Germany.

Authors:  Enno Nowossadeck
Journal:  Dtsch Arztebl Int       Date:  2012-03-02       Impact factor: 5.594

7.  Are religion and religiosity important to end-of-life decisions and patient autonomy in the ICU? The Ethicatt study.

Authors:  Hans-Henrik Bülow; Charles L Sprung; Mario Baras; Sara Carmel; Mia Svantesson; Julie Benbenishty; Paulo A Maia; Albertus Beishuizen; Simon Cohen; Daniel Nalos
Journal:  Intensive Care Med       Date:  2012-04-14       Impact factor: 17.440

8.  Intensive care unit cultures and end-of-life decision making.

Authors:  Judith Gedney Baggs; Sally A Norton; Madeline H Schmitt; Mary T Dombeck; Craig R Sellers; Jill R Quinn
Journal:  J Crit Care       Date:  2007-02-08       Impact factor: 3.425

9.  The importance of religious affiliation and culture on end-of-life decisions in European intensive care units.

Authors:  Charles L Sprung; Paulo Maia; Hans-Henrik Bulow; Bara Ricou; Apostolos Armaganidis; Mario Baras; Elisabet Wennberg; Konrad Reinhart; Simon L Cohen; Dietmar R Fries; George Nakos; Lambertius G Thijs
Journal:  Intensive Care Med       Date:  2007-06-01       Impact factor: 17.440

Review 10.  Cultural perspectives of death, grief, and bereavement.

Authors:  Paul T Clements; Gloria J Vigil; Martin S Manno; Gloria C Henry; Jonathan Wilks; Rosie Kellywood; Wil Foster
Journal:  J Psychosoc Nurs Ment Health Serv       Date:  2003-07       Impact factor: 1.098

View more
  1 in total

Review 1.  [Intensive and palliative care medicine. From academic distance to caring affection].

Authors:  H Burchardi
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-02       Impact factor: 0.840

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.